Article Text


Short report
  1. H. Lundh,
  2. O. Nilsson,
  3. I. Rosén
  1. Department of Pharmacology, University of Lund, Lund, Sweden
  2. Department of Neurology, University of Lund, Lund, Sweden
  3. Department of Clinical Neurophysiology, University of Lund, Lund, Sweden


    A 67 year old man with the myasthenic syndrome associated with small cell bronchogenic carcinoma was treated with a new drug, 4-aminopyridine. The muscle weakness showed marked improvement and electrophysiological examinations demonstrated restoration of neuromuscular transmission.

    Statistics from

    4-Aminopyridine—a new drug tested in the treatment of Eaton-Lambert syndrome

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.